Pharmacophore an International Research Journal
Pharmacophore
Submit Manuscript
Open Access | Published: 2024 - Issue 2

Exploring the Impact of Momordica charantia on Diabetes Mellitus: From Cell Cultures to Clinical Studies Download PDF


, , , , , ,
  1. Department of Biomedical Sciences, University of Oradea, 410087 Oradea, Romania.
  2. Department of Preclinical Disciplines, Faculty of Medicine and Pharmacy, University of Oradea, 410073 Oradea, Romania.
  3. Department of Pharmacy, Faculty of Medicine and Pharmacy, University of Oradea, 410028 Oradea, Romania.
  4. Department of Medical Disciplines, Faculty of Medicine and Pharmacy, University of Oradea, 410073 Oradea, Romania.
Abstract

Momordica charantia (MC), commonly known as bitter melon, has garnered attention for its diverse pharmacological properties, particularly its potential in managing diabetes mellitus (DM) and associated complications. The present narrative review comprehensively assesses the scientific landscape surrounding MC's efficacy and safety in the context of diabetes and its related complications, encompassing neuropathy, nephropathy, impaired wound healing, retinopathy, dyslipidemia, fatty liver disease, hypertension, and atherosclerosis. Drawing insights from both experimental studies on animal models and clinical trials, the present evaluation reveals that MC exhibits notable hypoglycemic effects attributed to its rich phytochemistry, including bioactive components such as charatin, vicine, and various momordin compounds. Moreover, the herb demonstrates antioxidant, anti-inflammatory, and immunomodulatory properties, offering potential benefits in mitigating complications associated with DM. However, while animal model studies showcase promising results, clinical evidence remains somewhat inconclusive, necessitating further rigorous investigation. Nevertheless, in the context of diabetes’s incurable nature, MC emerges as a promising supplementary approach for diabetes management, showcasing mild outcomes with sustained efficacy and exhibiting a favorable safety profile.

Cite this article
Vancouver
Vesa CM, Bungau SG, Tit DM, Purza AL, Bungau AF, Radu AF, et al. Exploring the Impact of Momordica charantia on Diabetes Mellitus: From Cell Cultures to Clinical Studies. Pharmacophore. 2024;15(2):32-42. https://doi.org/10.51847/TiB6u3aEF5
APA
Vesa, C. M., Bungau, S. G., Tit, D. M., Purza, A. L., Bungau, A. F., Radu, A. F., & Stoicescu, M. (2024). Exploring the Impact of Momordica charantia on Diabetes Mellitus: From Cell Cultures to Clinical Studies. Pharmacophore, 15(2), 32-42. https://doi.org/10.51847/TiB6u3aEF5

Related articles:
Most viewed articles:
QR code:

Short Link:
Views: 626

Downloads: 75
Quick Access

Pharmacophore
ISSN: 2229-5402

Copyright © 2024 Pharmacophore, All rights are reserved and for all open access contents, the Creative Commons licensing terms apply.
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.